Evidence map›Paper›PMID 40333294›Full record

ArticleVaccines2025

Therapeutic Vaccinations with p210 Peptides in Imatinib-Treated Chronic Myeloid Leukemia Patients: 10 Years Follow-Up of GIMEMA CML0206 and SI0207 Studies.

Anna Sicuranza, Massimo Breccia, Francesco Iuliano, Gabriele Gugliotta, Fausto Castagnetti, Monia Lunghi, Andrea Patriarca, Tamara Intermesoli, Luigiana Luciano, Antonella Russo Rossi and 17 more

Abstract read
In one paragraph

Article in Vaccines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Anna SicuranzaHematology Unit, Azienda Ospedaliera Universitaria Senese, University of Siena, 53100 Siena, Italy.ORCID 0000-0002-5840-2956
Massimo BrecciaDepartment of Translational and Precision Medicine, Sapienza University, 00161 Rome, Italy.ORCID 0000-0003-1163-6162
Francesco IulianoPresidio Ospedaliero N. Giannetasio, Azienda ASL 3, 87068 Rossano, Italy.
Gabriele GugliottaInstitute of Hematology "L. and A. Seràgnoli", Department of Experimental, Diagnostic and Specialty Medicine, "S. Orsola-Malpighi" University Hospital, University of Bologna, 40138 Bologna, Italy.
Fausto CastagnettiInstitute of Hematology "L. and A. Seràgnoli", Department of Experimental, Diagnostic and Specialty Medicine, "S. Orsola-Malpighi" University Hospital, University of Bologna, 40138 Bologna, Italy.
Monia LunghiDivision of Hematology, Department of Translational Medicine, University of Eastern Piedmont and AOU Maggiore della Carità, 28100 Novara, Italy.
Andrea PatriarcaDivision of Hematology, Department of Translational Medicine, University of Eastern Piedmont and AOU Maggiore della Carità, 28100 Novara, Italy.ORCID 0000-0003-4415-2906
Tamara IntermesoliHematology and Bone Marrow Transplant Unit, ASST Papa Giovanni XXIII, 24127 Bergamo, Italy.
Luigiana LucianoHematology Unit "Federico II", University of Naples, 80138 Naples, Italy.
Antonella Russo RossiHematology and Stem Cell Transplantation Unit, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari "Aldo Moro", 70121 Bari, Italy.
Giovanna Rege CambrinDivision of Internal Medicine and Hematology, San Luigi Gonzaga Hospital, 10043 Turin, Italy.
Vladan VucinicKlinik und Poliklinik für Hämatologie, Zelltherapie und Hämostaseologie, University Hospital Leipzig, 04103 Leipzig, Germany.ORCID 0000-0002-8398-285X
Michele MalagolaDepartment of Clinical and Experimental Sciences, University of Brescia, Unit of Blood Diseases and Bone Marrow Transplant, ASST Spedali Civili, 25123 Brescia, Italy.ORCID 0000-0003-0907-130X
Alessandra MalatoA.O. Ospedali Riuniti Villa Sofia-Cervello-P.O. Cervello, 90146 Palermo, Italy.
Elisabetta AbruzzeseDivision of Hematology, S. Eugenio Hospital, 00144 Rome, Italy.ORCID 0000-0001-5228-6491
Mariella D'AddaDivision of Hematology, ASST-Spedali Civili di Brescia, 25123 Brescia, Italy.
Sara GalimbertiSection of Hematology, Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy.
Marzia DefinaHematology Unit, Azienda Ospedaliera Universitaria Senese, University of Siena, 53100 Siena, Italy.
Vincenzo SammartanoHematology Unit, Azienda Ospedaliera Universitaria Senese, University of Siena, 53100 Siena, Italy.
Cristiana CafarelliHematology Unit, Azienda Ospedaliera Universitaria Senese, University of Siena, 53100 Siena, Italy.
Emanuele CenciniHematology Unit, Azienda Ospedaliera Universitaria Senese, University of Siena, 53100 Siena, Italy.
Alessandra CartocciDepartment of Medical Sciences, Surgery and Neurosciences, University of Siena, 53100 Siena, Italy.ORCID 0000-0002-1818-6275
Paola PacelliHematology Unit, Azienda Ospedaliera Universitaria Senese, University of Siena, 53100 Siena, Italy.ORCID 0000-0001-5838-1123
Alfonso PiciocchiGIMEMA Foundation, 00182 Rome, Italy.ORCID 0000-0001-8648-885X
Arianna RughiniGIMEMA Foundation, 00182 Rome, Italy.
Dietger NiederwieserKlinik und Poliklinik für Hämatologie, Zelltherapie und Hämostaseologie, University Hospital Leipzig, 04103 Leipzig, Germany.ORCID 0000-0002-4737-1103
Monica BocchiaHematology Unit, Azienda Ospedaliera Universitaria Senese, University of Siena, 53100 Siena, Italy.ORCID 0000-0003-3538-3913

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CMLimatinibimmune therapypeptidevaccine

Identifiers

PMID40333294
PMCPMC12031404

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.